The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of 20.7 billion to 22.1 billion euros.

FRANKFURT, Nov 14 (Reuters) - Merck KGaA (MRCG.DE), opens new tab on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by temporarily lower spending on drug development and a rebound in demand for its specialty materials. The German ...

Driven by growth across the board, including in its semiconductor business, German science and technology company Merck reported profit after tax of €812 million ($857 million) or €1.86 per share for the third quarter.

Merck reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in life-sciences, but cautioned that full-year sales would come in at the bottom end of the forecast range.